EndocrinologyObstetrics & Gynaecology
Polycystic Ovary Syndrome (PCOS)
Rotterdam criteria, exclude differentials, lifestyle + metformin / OCP / clomiphene / letrozole, screen for cardiometabolic risk.
Source: International PCOS Guideline 2023; NICE CKS
Step 1 of ~4
info
Rotterdam Criteria (2 of 3)
• Oligo/anovulation.
• Clinical or biochemical hyperandrogenism (hirsutism, acne, alopecia; ↑ free testosterone).
• Polycystic ovaries on USS (≥12 follicles 2–9 mm in either ovary OR ovarian volume >10 mL).
Must exclude other causes of menstrual disturbance + hyperandrogenism.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Decision support only. Always apply local guidelines and clinical judgement.